Figure 2.

Clinical outcomes after CD25/Treg-depleted DLI at dose level 2. (A) Kaplan Meier curves demonstrating overall survival after infusion for recipients of CD25/Treg-depleted DLI at 3×10⁷ CD3⁺/kg (solid line) versus unmanipulated DLI at cell doses of 2.2–3.7×10⁷ CD3⁺/kg (dotted line). (B) Kaplan Meier curves demonstrating improved event-free survival after CD25/Treg-depleted DLI (solid line) versus unmanipulated DLI (dotted line). (C) Relapse and non-relapse mortality: plot displaying cumulative incidences of disease relapse and non-relapse mortality after CD25/Treg-depleted DLI (solid and fine dotted lines, respectively) versus unmanipulated DLI (hashed and coarse dotted lines, respectively).